NIH-funded research R01 grant

How aging affects prostate cancer through immune cell imbalance

Official title: The Impact of Aging on Prostate Cancer with Age-Related Disruption of Th17/Treg Axis

Funded at Tulane University of Louisiana · NIH-11007185 · Data updated 2026-11-12

This study looks at how getting older affects the immune system and may increase the risk of prostate cancer, aiming to find new ways to prevent or treat the disease in older men.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startJanuary 1, 2021
Project endDecember 31, 2025
Funding year2025
Award (this year)$347,700
NIH project number5R01CA255802-05
Project IDNIH-11007185 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are elderly men who are at risk for or diagnosed with prostate cancer.

Less likely to help

Patients who are younger or do not have prostate cancer may not benefit from this research.

What this research studies

This research investigates the relationship between aging and prostate cancer, focusing on how age-related changes in immune cells may contribute to the disease. It examines the balance between pro-inflammatory Th17 cells and regulatory T (Treg) cells, which is disrupted in older adults, potentially leading to increased cancer risk. By studying prostate tissue and immune responses in elderly patients and aged mice, the research aims to uncover mechanisms that drive prostate cancer progression in older men. The ultimate goal is to develop new strategies for preventing or treating prostate cancer in the aging population.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments or preventive measures for prostate cancer specifically tailored for older men.

How similar studies have gone: Previous research has indicated that immune cell imbalances contribute to cancer progression, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Zhang, Qiuyang — Tulane University of Louisiana
  • Study coordinator: Zhang, Qiuyang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.